Therapeutic Validation of GEF-H1 Using a De Novo Designed Inhibitor in Models of Retinal Disease.
Mills C, Hemkemeyer SA, Alimajstorovic Z, Bowers C, Eskandarpour M, Greenwood J, Calder V, Chan AWE, Gane PJ, Selwood DL, Matter K, Balda MS.
Mills C, et al. Among authors: matter k.
Cells. 2022 May 24;11(11):1733. doi: 10.3390/cells11111733.
Cells. 2022.
PMID: 35681428
Free PMC article.